Join ASH in our relentless pursuit of change, as we actively shape policies that impact the very heart of hematology research and practice. We empower researchers, clinicians, and patients through education, equipping lawmakers and government officials with the knowledge they need to make a difference. Together, we unite our voice to revolutionize the future of hematology for the better.
ASH Advocacy's Latest Impact on Hematology
Tell Congress to Protect Research Funding!
Timing is critical! Urge your members of Congress to support the highest possible funding level for National Institutes of Health (NIH) before current appropriations run out on January 30. Make your voice heard and speak up to help push innovation forward. Scientists, clinicians, and, most especially, patients, depend on it.
Advocacy News Roundup
Recapping Top Stories from December 2025
Senate Seeks to Move Forward on FY 2026 Funding Before End of Year
ASH Comments for the December 2025 Meeting of the Advisory Committee on Immunization Practices
ASH Joins AMA Letter Supporting the Senior's Timely Access to Care Act
Federal Rule Summaries
See summaries of the latest rules on hematology-related topics.Policy Statements
Explore ASH's statements regarding research, practice, training, and quality of care within the field.Testimony and Correspondence
View formal congressional testimony and correspondence related to issues affecting hematologists and their patients.
#Fight4Hematology
As the world’s largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases, ASH is fighting for hematology in the face of executive orders and other federal actions that threaten hematology research and, ultimately, the care of patients.
Research and Public Health Funding
ASH and other members of the biomedical research and public health communities continue to strongly urge Congress to provide increased annual funding for NIH, CDC, and other federal public health agencies and programs. Increased resources are needed now more than ever.
Access to Palliative Blood Transfusions
Misconceptions about transfusions and limited funds hinder access to patients' end-of-life care. ASH prompts calls for innovative reimbursement models and increased support for palliative transfusions in hospice settings.
Sickle Cell Disease Advocacy
Since 2015, ASH has been committed to improving the outcomes for individuals living with SCD through collaborations with federal agencies, the U.S. Congress, and the U.S. Department of Health and Human Services.
Maternal Health Care
Maternal morbidity and mortality closely intersect with hematology, and ASH is committed to supporting the right to maternal health care. This includes approaches to address hematologic disorders, advocating for access to reproductive health services for all people, and combating inequities in hematology. ASH works to support clinicians who serve vulnerable populations, including those at risk of maternal health conditions.
The ASH Congressional Fellowship is a yearlong opportunity that allows an ASH member to work in a congressional office on Capitol Hill, Washington, DC, for an academic year to help shape health care and hematology policy.
Advocacy Leadership Institute (ALI)
ALI is a two-day workshop in Washington, DC, where ASH members can gain a better understanding of the Society, learn about how Congress and health policy impact hematology research and practice, and meet with members of Congress and their staff on Capitol Hill.
ASH-FDA Collaboration
This Collaboration is a two-day workshop in Washington, DC, co-hosted by the U.S. Food and Drug Administration, for ASH members to network with FDA staff and learn about clinical and translational research, drug development, and regulatory medicine.